LOGIN
Loading...
Search Filters
Date Range
toReport Types
Condition
See all (5)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 16 of 16
Etanercept with methotrexate more effectively maintains low disease activity in RA
Lancet. 2013 Mar 16;381(9870):918-29. doi: 10.1016/S0140-6736(12)61811-X. Epub 2013 Jan 17
Juvenile RA: Fewer disease flares with Adalimumab (TNF Antibody)
N Engl J Med. 2008 Aug 21;359(8):810-20
Osteosarcoma: methotrexate & doxorubicin versus methotrexate, etoposide & ifosfamide
Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30
TNF antagonist better in treatment of early rheumatoid arthritis
Lancet. 2009 Aug 8;374(9688):459-66.
RA: Addition of etanercept to methotrexate increases remission rates
Lancet. 2008 Aug 2;372(9636):375-82. Epub 2008 Jul 16
Ifosfamide not necessary in chemotherapy for nonmetastatic osteosarcoma
J Clin Oncol. 2012 Jun 10;30(17):2112-8. doi: 10.1200/JCO.2011.38.4420. Epub 2012 May 7
Tocilizumab more effective in reducing rheumatoid arthritis symptoms than adalimumab
Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18
Muramyl tripeptide in chemotherapy improves overall osteosarcoma survival
J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095
Rheumatoid arthritis: Improvement in clinical outcome similar between 4 drug therapies
Ann Intern Med. 2007 Mar 20;146(6):406-15
MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients
Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566
Osteosarcoma: 25 year survival rate significantly improved with adjuvant chemotherapy
Cancer. 2012 Dec 1;118(23):5888-93
Tocilizumab treatment in systemic juvenile idiopathic arthritis
N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802
Golimumab treatment provides superior treatment of rheumatoid arthritis
Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26
Showing 1 - 16 of 16